Posts

Regenerative Medicine’s Heroic Trio

PRP, BMAC, and MFAT (microfat) are the three primary regenerative medicine substances. The pros and cons of each are briefly discussed.

Jointechlabs Secures CE Mark Approval for Mini-Stem System in Europe, Will Soon Launch Regenerative Medicine Product

Mini-Stem System has received CE Mark approval

Dr. Nathan Katz Adipose Seminar at TOBI

Excerpts from a presentation by Dr. Nathan Katz, CEO of Jointechlabs, to The Orthobiologic Insititute, on August 14, 2024.

Orthopedic Surgery – Should I Have it or Not?

Orthopedic surgery presents hope – and risks. There are alternatives, including microfat, that should be considered.

Scientific Papers and Presentations – Summer 2024

Dr. Mitchell Sheinkop discusses Jointechlabs’ recent presentation of scientific papers at orthobiologic conferences in Europe.

Chicken Soup for Arthritis
-or-
Micro-Fragmented Adipose Tissue

Chicken soup was and is a popular cure-all. Today, joint preservation with orthobiologics such as microfragmented adipose tissue for grades 2-3 osteoarthritis is an emerging standard of care.

The Global Regenerative Medicine Market: a Rising Tide and a Prime Investment Opportunity

The rising global market for regenerative medicine not only offers hope in the form of advanced therapies but also presents a fertile ground for robust investment returns.

Jointechlabs Adds Orthopedic and Aesthetic Depth to Scientific Advisory Board

Renowned doctors Dr. William D. Murrell (orthopedics) and Dr. Carlos Mercado (aesthetics) bring new scientific and market savvy to the company.

When BMAC (Bone Marrow) Isn’t Indicated, Microfat May Be!

BMAC and microfat both provide orthopedic advantages. Microfat can also be used when BMAC is not indicated.

Jointechlabs’ CEO on “Talk is Biotech”

“Join us on the Talk is Biotech! podcast as we chat with Nathan Katz about his incredible journey from completing his PhD to becoming a medical scientist and ultimately a successful CEO of Jointechlabs, Inc.”